The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 13, 2021

Filed:

May. 06, 2016
Applicant:

University of Kentucky Research Foundation, Lexington, KY (US);

Inventors:

Peixuan Guo, Columbus, OH (US);

Dan Shu, Columbus, OH (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/00 (2006.01); G01N 33/53 (2006.01); C12Q 1/02 (2006.01); G16B 15/00 (2019.01); G16C 10/00 (2019.01); G16C 20/20 (2019.01); G16C 20/50 (2019.01); C12Q 3/00 (2006.01); G01N 33/68 (2006.01); G01N 33/94 (2006.01); G06G 7/58 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/025 (2013.01); C12Q 3/00 (2013.01); G01N 33/68 (2013.01); G01N 33/94 (2013.01); G06G 7/58 (2013.01); G16B 15/00 (2019.02); G16C 10/00 (2019.02); G16C 20/20 (2019.02); G16C 20/50 (2019.02); G01N 33/53 (2013.01); G01N 2333/005 (2013.01); G01N 2333/195 (2013.01); G01N 2333/37 (2013.01); G01N 2500/00 (2013.01);
Abstract

A method is described for the identification of multi-subunit biocomplex drug targets. The method includes identifying a target that performs a biological function, wherein the target comprises one or more subunits, wherein a minimum number of the one or more subunits is inactivated to inhibit the biological function. The method includes selecting a drug that binds specifically to each subunit of the one or more subunits with a target probability. The method describes a relationship between inhibition efficiency of the drug and total number of the one or more subunits using a binomial distribution, wherein the inhibition efficiency comprises a probability that the delivered drug blocks the biological function. The method includes confirming empirically the relationship using an experimental target. The method includes administering the drug to the target to treat a multi-drug resistant disease, wherein the target comprises a biological complex in a mammalian subject.


Find Patent Forward Citations

Loading…